Publications by authors named "Areeka Irfan"
Article Synopsis
- Percutaneous coronary intervention (PCI) is a common treatment for obstructive coronary artery disease, but patients with a history of coronary artery bypass grafting (CABG) often experience worsened clinical outcomes compared to those without CABG history.
- A systematic review and meta-analysis of 16 studies involving over 250,000 patients revealed that CABG patients had higher rates of short-term and long-term mortality, myocardial infarction, and other major adverse events during PCI, while CABG-naïve patients faced more risks of cardiac tamponade and needing repeat CABG.
- The findings suggest that patients with prior CABG have more complex heart issues and additional health problems, highlighting the need
This meta-analysis investigates the association between testosterone replacement therapy [TRT] and carotid artery atherosclerosis. 3 databases were searched for studies up to June 2023 per the PRISMA guidelines. The eligibility criteria comprised RCTs and observational studies involving hypogonadal males receiving exogenous testosterone, in which CIMT was assessed.
View Article and Find Full Text PDFBackground: There is a lack of evidence that directly shows the best antihypertensive treatment options for post partum management of the hypertensive disorders of pregnancy. Our objective was to analyze the safest and most effective antihypertensive drugs post partum for patients with hypertensive disorders of pregnancy.
Methods: PubMed, Cochrane, and MEDLINE were searched to find relevant articles published from inception to Feb 2024.
Background: Clinical guidelines recommend statin use in patients with a vast array of cardiovascular disturbances. However, there is insufficient evidence regarding the concomitant use of omega-3 fatty acids in addition to statins. This meta-analysis aims to uncover the complete effects of this combination therapy on cardiovascular outcomes, lipid biomarkers, inflammatory markers, and plaque markers.
View Article and Find Full Text PDFAim: This meta-analysis was performed to assess the efficacy and safety of mavacamten in patients with hypertrophic cardiomyopathy.
Methods & Materials: A search was conducted using PubMed, Cochrane, and Scopus up to August 2022 for randomized studies reporting our pre-specified outcomes.
Results: It was observed that mavacamten significantly improved New York Heart Association class (p < 0.